Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
JCI Insight|December 6, 2021
Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infectionsMark J Siedner, Julie Boucau, Rebecca F Gilbert, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 23, 2022
Characterization of Virologic Rebound Following Nirmatrelvir-Ritonavir Treatment for Coronavirus Disease 2019 (COVID-19)Julie Boucau, Rockib Uddin, Caitlin Marino, et al.Dermatologic Clinics|September 24, 2021
Dermatology COVID-19 Registries: Updates and Future DirectionsEsther E Freeman, Grace C Chamberlin, Devon E McMahon, et al.Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
Duration of viable virus shedding in SARS-CoV-2 omicron variant infectionJulie Boucau, Caitlin Marino, James Regan, et al.Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody ResponsesMichael S Seaman, Mark J Siedner, Julie Boucau, et al.JCI Insight|October 10, 2022
Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variantMichael S Seaman, Mark J Siedner, Julie Boucau, et al.Pageof 1